{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T15:38:15Z","timestamp":1777217895887,"version":"3.51.4"},"reference-count":133,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Acromegaly is described as the oversecretion of growth hormone (GH) and, subsequently,\ninsulin-like growth factor 1 (IGF-1), ascribed in most cases to a pituitary adenoma. This\ndisease presents a progressive disfigurement, along with other systemic manifestations, which altogether\ndiminishes the quality of life in the patients. Prolonged exposure to abnormally high levels\nof GH and IGF-1 levels results in cardiovascular, cerebrovascular, and pulmonary dysfunction\nwhich overall produces a fall in life expectancy. Timely diagnosis and further treatment decreased\nthe mortality rate of the patients and showed an improvement in the quality of life. Surgical procedures,\nadvanced radiation therapy tools, and the availability of pharmacological compounds that act\non pituitary growth hormone-producing cells have enabled an improved approach to treating the\ndisease. Pharmacological treatment is currently an important management option, and it may also\nbe the first-line treatment in patients with acromegaly who do not benefit from or are ineligible for\nfirst-line surgical procedures. From its inception until 2021, we used a comprehensive search strategy\non Medline\/PubMed, Scopus, Embase, Web of Science, and the Cochrane Library electronic\ndatabases. All human research articles and review articles published in English were considered for\nthe review. In this review, we describe the clinical implications and management of patients with\nacromegaly, consisting of scientific improvements underlying the developing understanding of\npathogenesis and diagnosis, associated comorbidities and mortality rate with the disease, and major\nimprovements in the treatment of the disease, along with novel strategies including quality of life\nand patient-reported outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530322666221012155533","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T06:21:45Z","timestamp":1665728505000},"page":"748-763","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Growth Hormone Excess: Implications and Management"],"prefix":"10.2174","volume":"23","author":[{"given":"Suneela","family":"Dhaneshwar","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrishti","family":"Shandily","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vatsalya","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ghir.2005.06.007","volume":"15","author":"Katznelson L.","year":"2005","unstructured":"Katznelson L.; Diagnosis and treatment of acromegaly. Growth Horm IGF Res 2005,15,31-35","journal-title":"Growth Horm IGF Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","volume":"66","author":"O\u2019Reilly K.E.","year":"2006","unstructured":"O\u2019Reilly K.E.; Rojo F.; She Q.B.; Solit D.; Mills G.B.; Smith D.; Lane H.; Hofmann F.; Hicklin D.J.; Ludwig D.L.; Baselga J.; Rosen N.; mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 2006,66(3),1500-1508","journal-title":"Cancer Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJMx070007","volume":"356","year":"2007","unstructured":"Medical progress: Acromegaly N Engl J Med 2007,356(8),879-879","journal-title":"Acromegaly N Engl J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2010.7.FOCUS10169","volume":"29","author":"Lopes M.B.S.","year":"2010","unstructured":"Lopes M.B.S.; Growth hormone-secreting adenomas: Pathology and cell biology. Neurosurg Focus 2010,29(4),E2","journal-title":"Neurosurg Focus"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000095524","volume":"83","author":"Horvath E.","year":"2006","unstructured":"Horvath E.; Kovacs K.; Pathology of acromegaly. Neuroendocrinology 2006,83(3-4),161-165","journal-title":"Neuroendocrinology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"Mete O.","year":"2017","unstructured":"Mete O.; Lopes M.B.; Overview of the 2017 WHO Classification of pituitary tumors. Endocr Pathol 2017,28(3),228-243","journal-title":"Endocr Pathol"},{"key":"ref=7","first-page":"1","author":"Kovacs K.","year":"1986","unstructured":"Kovacs K.; Tumors of the pituitary gland. Atlases of Tumor and Non-tumor Pathology 1986,1-269","journal-title":"Atlases of Tumor and Non-tumor Pathology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12020-014-0383-y","volume":"49","author":"Kiseljak V.K.","year":"2015","unstructured":"Kiseljak V.K.; Carlson N.E.; Borges M.T.; DeMasters K.B.K.; Lillehei K.O.; Kerr J.M.; Wierman M.E.; Growth hormone tumor histo-logical subtypes predict response to surgical and medical therapy. Endocrine 2015,49(1),231-241","journal-title":"Endocrine"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11102-012-0445-1","volume":"16","author":"Brzana J.","year":"2013","unstructured":"Brzana J.; Yedinak C.G.; Gultekin S.H.; Delashaw J.B.; Fleseriu M.; Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary 2013,16(4),490-498","journal-title":"Pituitary"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-12-0864","volume":"168","author":"Larkin S.","year":"2013","unstructured":"Larkin S.; Reddy R.; Karavitaki N.; Cudlip S.; Wass J.; Ansorge O.; Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-na&#xEF;ve patients with somatotroph adenomas. Eur J Endocrinol 2013,168(4),491-499","journal-title":"Eur J Endocrinol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","volume":"19","author":"Obari A.","year":"2008","unstructured":"Obari A.; Sano T.; Ohyama K.; Kudo E.; Qian Z.R.; Yoneda A.; Rayhan N.; Mustafizur R.M.; Yamada S.; Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 2008,19(2),82-91","journal-title":"Endocr Pathol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-10-0586","volume":"163","author":"Bakhtiar Y.","year":"2010","unstructured":"Bakhtiar Y.; Hirano H.; Arita K.; Yunoue S.; Fujio S.; Tominaga A.; Sakoguchi T.; Sugiyama K.; Kurisu K.; Yasufuku T.J.; Takano K.; Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. Eur J Endocrinol 2010,163(4),531-539","journal-title":"Eur J Endocrinol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3390\/jcm8111962","volume":"8","author":"Akirov A.","year":"2019","unstructured":"Akirov A.; Asa S.L.; Amer L.; Shimon I.; Ezzat S.; The clinicopathological spectrum of acromegaly. J Clin Med 2019,8(11),1962","journal-title":"J Clin Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1210\/jcem.86.9.7819","volume":"86","author":"Kreutzer J.","year":"2001","unstructured":"Kreutzer J.; Vance M.L.; Lopes M.B.S.; Laws E.R.;  Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 2001,86(9),4072-4077","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"Melmed S.","year":"2011","unstructured":"Melmed S.; Pathogenesis of pituitary tumors. Nat Rev Endocrinol 2011,7(5),257-266","journal-title":"Nat Rev Endocrinol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L","volume":"47","author":"Horvath E.","year":"1981","unstructured":"Horvath E.; Kovacs K.; Singer W.; Smyth H.S.; Killinger D.W.; Erzin C.; Weiss M.H.; Acidophil stem cell adenoma of the human pituitary: Clinicopathologic analysis of 15 cases. Cancer 1981,47(4),761-771","journal-title":"Cancer"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3803\/EnM.2015.30.3.389","volume":"30","author":"Chin S.O.","year":"2015","unstructured":"Chin S.O.; Hwang J.K.; Rhee S.Y.; Chon S.; Oh S.; Lee M.; Pellegata N.S.; Kim S.W.; Acromegaly due to a macroinvasive plurihormonal pituitary adenoma and a rectal carcinoid tumor. Endocrinol Metab 2015,30(3),389-394","journal-title":"Endocrinol Metab"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-11-0216","volume":"165","author":"Wade A.N.","year":"2011","unstructured":"Wade A.N.; Baccon J.; Grady M.S.; Judy K.D.; O\u2019Rourke D.M.; Snyder P.J.; Clinically silent somatotroph adenomas are common. Eur J Endocrinol 2011,165(1),39-44","journal-title":"Eur J Endocrinol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.seminoncol.2010.10.012","volume":"37","author":"Sansur C.A.","year":"2010","unstructured":"Sansur C.A.; Oldfield E.H.; Pituitary carcinoma. Semin Oncol 2010,37(6),591-593","journal-title":"Semin Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"645914","DOI":"10.1155\/2012\/645914","volume":"2012","author":"Morokuma H.","year":"2012","unstructured":"Morokuma H.; Ando T.; Hayashida T.; Horie I.; Inoshita N.; Murata F.; Ueki I.; Nakamura K.; Imaizumi M.; Kawakami A.; A case of nonfunctioning pituitary carcinoma that responded to temozolomide treatment. Case Rep Endocrinol 2012,2012,645914","journal-title":"Case Rep Endocrinol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.humpath.2008.06.013","volume":"40","author":"Scheithauer B.W.","year":"2009","unstructured":"Scheithauer B.W.; Kovacs K.; Nose V.; Lombardero M.; Osamura Y.R.; Lloyd R.V.; Horvath E.; Pagenstecher A.; Bohl J.E.; Tews D.S.; Multiple endocrine neoplasia type 1\u2013associated thyrotropin-producing pituitary carcinoma: Report of a probable de novo example. Hum Pathol 2009,40(2),270-278","journal-title":"Hum Pathol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.25259\/SNI_176_2019","volume":"10","author":"Sinclair G.","year":"2019","unstructured":"Sinclair G.; Olsson M.; Benmakhlouf H.; Al-Saffar Y.; Johnstone P.; Hatiboglu M.A.; Shamikh A.; Pituitary carcinomas: Rare and challenging. Surg Neurol Int 2019,10,161","journal-title":"Surg Neurol Int"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11102-013-0489-x","volume":"17","author":"Balili I.","year":"2014","unstructured":"Balili I.; Sullivan S.; Mckeever P.; Barkan A.; Pituitary carcinoma with endolymphatic sac metastasis. Pituitary 2014,17(3),210-213","journal-title":"Pituitary"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/978-1-59259-963-9_39","author":"Thakker R.V.","year":"2006","unstructured":"Thakker R.V.; Multiple endocrine neoplasia type 1. Principles of Molecular Medicine 2006,386-392","journal-title":"Principles of Molecular Medicine"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jc.2013-3826","volume":"99","author":"Salenave S.","year":"2014","unstructured":"Salenave S.; Boyce A.M.; Collins M.T.; Chanson P.; Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 2014,99(6),1955-1969","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-1-21","volume":"1","author":"Bertherat J.","year":"2006","unstructured":"Bertherat J.; Carney Complex (CNC). Orphanet J Rare Dis 2006,1(1),21","journal-title":"Orphanet J Rare Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1172\/JCI110708","volume":"70","author":"Thorner M.O.","year":"1982","unstructured":"Thorner M.O.; Perryman R.L.; Cronin M.J.; Rogol A.D.; Draznin M.; Johanson A.; Vale W.; Horvath E.; Kovacs K.; Somatotroph hyperplasia. J Clin Invest 1982,70(5),965-977","journal-title":"J Clin Invest"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1056\/NEJM200006223422504","volume":"342","author":"Beuschlein F.","year":"2000","unstructured":"Beuschlein F.; Strasburger C.J.; Siegerstetter V.; Moradpour D.; Lichter P.; Bidlingmaier M.; Blum H.E.; Reincke M.; Acromegaly caused by secretion of growth hormone by a non-Hodgkin\u2019s lymphoma. N Engl J Med 2000,342(25),1871-1876","journal-title":"N Engl J Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1093\/annonc\/12.suppl_2.S89","volume":"12","author":"Doga M.","year":"2001","unstructured":"Doga M.; Bonadonna S.; Burattin A.; Giustina A.; Ectopic secretion of Growth Hormone-Releasing Hormone (GHRH) in neuroendocrine tumors: Relevant clinical aspects. Ann Oncol 2001,12(Suppl. 2),S89-S94","journal-title":"Ann Oncol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11154-007-9060-2","volume":"9","author":"Cordero R.A.","year":"2008","unstructured":"Cordero R.A.; Barkan A.L.; Current diagnosis of acromegaly. Rev Endocr Metab Disord 2008,9(1),13-19","journal-title":"Rev Endocr Metab Disord"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11102-013-0471-7","volume":"17","author":"Alexopoulou O.","year":"2014","unstructured":"Alexopoulou O.; Bex M.; Kamenicky P.; Mvoula A.B.; Chanson P.; Maiter D.; Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 2014,17(1),81-89","journal-title":"Pituitary"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cca.2010.11.008","volume":"412","author":"Clemmons D.R.","year":"2011","unstructured":"Clemmons D.R.; Clinical laboratory indices in the treatment of acromegaly. Clin Chim Acta 2011,412(5-6),403-409","journal-title":"Clin Chim Acta"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","volume":"57","author":"Clemmons D.R.","year":"2011","unstructured":"Clemmons D.R.; Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 2011,57(4),555-559","journal-title":"Clin Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11102-011-0302-7","volume":"15","author":"Rosario P.W.","year":"2012","unstructured":"Rosario P.W.; Calsolari M.R.; Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units. Pituitary 2012,15(2),179-183","journal-title":"Pituitary"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1210\/jc.2011-0237","volume":"96","author":"Schneider H.J.","year":"2011","unstructured":"Schneider H.J.; Kosilek R.P.; G&#xFC;nther M.; Roemmler J.; Stalla G.K.; Sievers C.; Reincke M.; Schopohl J.; W&#xFC;rtz R.P.; A novel ap-proach to the detection of acromegaly: accuracy of diagnosis by automatic face classification. J Clin Endocrinol Metab 2011,96(7),2074-2080","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1210\/jc.83.11.3808","volume":"83","author":"Freda P.U.","year":"1998","unstructured":"Freda P.U.; Post K.D.; Powell J.S.; Wardlaw S.L.; Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 1998,83(11),3808-3816","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"Giustina A.","year":"2010","unstructured":"Giustina A.; Chanson P.; Bronstein M.D.; Klibanski A.; Lamberts S.; Casanueva F.F.; Trainer P.; Ghigo E.; Ho K.; Melmed S.; A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010,95(7),3141-3148","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11102-009-0205-z","volume":"14","author":"Daud S.","year":"2011","unstructured":"Daud S.; Hamrahian A.H.; Weil R.J.; Hamaty M.; Prayson R.A.; Olansky L.; Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration? Pituitary 2011,14(4),414-417","journal-title":"Pituitary"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrendo.2014.181","volume":"11","author":"Lecoq A.L.","year":"2015","unstructured":"Lecoq A.L.; Kamenick&#xFD; P.; Guiochonl M.A.; Chanson P.; Genetic mutations in sporadic pituitary adenomas\u2014what to screen for? Nat Rev Endocrinol 2015,11(1),43-54","journal-title":"Nat Rev Endocrinol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-17-0253","volume":"24","author":"Petrossians P.","year":"2017","unstructured":"Petrossians P.; Daly A.F.; Natchev E.; Maione L.; Blijdorp K.; Sahnoun F.M.; Auriemma R.; Diallo A.M.; Hulting A.L.; Ferone D.; Hana V.; Filipponi S.; Sievers C.; Nogueira C.; Fajardo M.C.; Carvalho D.; Hana V.; Stalla G.K.; Jaffrain R.M.L.; Delemer B.; Colao A.; Brue T.; Neggers S.J.C.M.M.; Zacharieva S.; Chanson P.; Beckers A.; Acromegaly at diagnosis in 3173 patients from the Li&#xE8;ge Acromegaly Survey (LAS) database. Endocr Relat Cancer 2017,24(10),505-518","journal-title":"Endocr Relat Cancer"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/B978-0-444-59602-4.00014-9","volume":"124","author":"Chanson P.","year":"2014","unstructured":"Chanson P.; Salenave S.; Kamenicky P.; Acromegaly. Handb Clin Neurol 2014,124,197-219","journal-title":"Handb Clin Neurol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"Colao A.","year":"2004","unstructured":"Colao A.; Ferone D.; Marzullo P.; Lombardi G.; Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocr Rev 2004,25(1),102-152","journal-title":"Endocr Rev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1020798430884","volume":"4","author":"Bondanelli M.","year":"2001","unstructured":"Bondanelli M.; Ambrosio M.R.; Degli U.E.C.; Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 2001,4(4),239-249","journal-title":"Pituitary"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1365-2265.2005.02370.x","volume":"63","author":"Vitale G.","year":"2005","unstructured":"Vitale G.; Pivonello R.; Auriemma R.S.; Guerra E.; Milone F.; Savastano S.; Lombardi G.; Colao A.; Hypertension in acromegaly and in the normal population: prevalence and determinants. Clin Endocrinol 2005,63(4),470-476","journal-title":"Clin Endocrinol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1056\/NEJM199910213411706","volume":"341","author":"Hunter J.J.","year":"1999","unstructured":"Hunter J.J.; Chien K.R.; Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999,341(17),1276-1283","journal-title":"N Engl J Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.7326\/0003-4819-34-6-1445","volume":"34","author":"Hejtmancik M.R.","year":"1951","unstructured":"Hejtmancik M.R.; Bradfield J.Y.; Herrman G.R.; Acromegaly and the heart: A clinical and pathologic study. Ann Intern Med 1951,34(6),1445-1456","journal-title":"Ann Intern Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0002-8703(80)90277-X","volume":"100","author":"Lie J.T.","year":"1980","unstructured":"Lie J.T.; Grossman S.J.; Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980,100(1),41-52","journal-title":"Am Heart J"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","volume":"54","author":"Colao A.","year":"2001","unstructured":"Colao A.; Marzullo P.; Di Somma C.; Lombardi G.; Growth hormone and the heart. Clin Endocrinol 2001,54(2),137-154","journal-title":"Clin Endocrinol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archinte.1938.00180100014002","volume":"61","author":"Courville C.","year":"1938","unstructured":"Courville C.; The heart in acromegaly. Arch Intern Med 1938,61(5),704-713","journal-title":"Arch Intern Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1365-2265.2001.01256.x","volume":"54","author":"Colao A.","year":"2001","unstructured":"Colao A.; Spiezia S.; Cerbone G.; Pivonello R.; Marzullo P.; Ferone D.; Di Somma C.; Assanti A.P.; Lombardi G.; Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol 2001,54(4),515-524","journal-title":"Clin Endocrinol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1210\/jc.2010-2225","volume":"96","author":"Paisley A.N.","year":"2011","unstructured":"Paisley A.N.; Banerjee M.; Rezai M.; Schofield R.E.; Balakrishnannair S.; Herbert A.; Lawrance J.A.L.; Trainer P.J.; Cruickshank J.K.; Changes in arterial stiffness but not carotid intimal thickness in acromegaly. J Clin Endocrinol Metab 2011,96(5),1486-1492","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/EJE-09-0945","volume":"162","author":"Akutsu H.","year":"2010","unstructured":"Akutsu H.; Kreutzer J.; Wasmeier G.; Ropers D.; Rost C.; M&#xF6;hlig M.; Wallaschofski H.; Buchfelder M.; Sch&#xF6;fl C.; Acromegaly per se does not increase the risk for coronary artery disease. Eur J Endocrinol 2010,162(5),879-886","journal-title":"Eur J Endocrinol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1210\/jc.2005-2857","volume":"91","author":"Cannavo S.","year":"2006","unstructured":"Cannavo S.; Almoto B.; Cavalli G.; Squadrito S.; Romanello G.; Vigo M.T.; Fiumara F.; Benvenga S.; Trimarchi F.; Acromegaly and coronary disease: An integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J Clin Endocrinol Metab 2006,91(10),3766-3772","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1210\/jcem.86.7.7635","volume":"86","author":"Melmed S.","year":"2001","unstructured":"Melmed S.; Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 2001,86(7),2929-2934","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"527","DOI":"10.7326\/0003-4819-115-7-527","volume":"115","author":"Grunstein R.R.","year":"1991","unstructured":"Grunstein R.R.; Ho K.Y.; Sullivan C.E.; Sleep apnea in acromegaly. Ann Intern Med 1991,115(7),527-532","journal-title":"Ann Intern Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1164\/ajrccm.150.2.8049836","volume":"150","author":"Grunstein R.R.","year":"1994","unstructured":"Grunstein R.R.; Ho K.Y.; Berthon J.M.; Stewart D.; Sullivan C.E.; Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 1994,150(2),496-502","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4158\/EP.17.4.636","volume":"17","author":"Katznelson L.","year":"2011","unstructured":"Katznelson L.; Atkinson J.L.D.; Cook D.M.; Ezzat S.Z.; Hamrahian A.H.; Miller K.K.; Ludlam W.H.; Samson S.L.; Waguespack S.G.; American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update. Endocr Pract 2011,17(4),636-646","journal-title":"Endocr Pract"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10067-013-2219-1","volume":"32","author":"Kropf L.L.","year":"2013","unstructured":"Kropf L.L.; Madeira M.; Neto L.V.; Roberto G.M.; De Farias M.L.F.; Functional evaluation of the joints in acromegalic patients and associated factors. Clin Rheumatol 2013,32(7),991-998","journal-title":"Clin Rheumatol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"Mazziotti G.","year":"2013","unstructured":"Mazziotti G.; Bianchi A.; Porcelli T.; Mormando M.; Maffezzoni F.; Cristiano A.; Giampietro A.; De Marinis L.; Giustina A.; Vertebral fractures in patients with acromegaly: A 3-year prospective study. J Clin Endocrinol Metab 2013,98(8),3402-3410","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0889-8529(18)30205-6","volume":"21","author":"Lieberman S.A.","year":"1992","unstructured":"Lieberman S.A.; Bj&#xF6;rkengren A.G.; Hoffman A.R.; Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am 1992,21(3),615-631","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000375450","volume":"103","author":"Claessen K.M.J.A.","year":"2016","unstructured":"Claessen K.M.J.A.; Mazziotti G.; Biermasz N.R.; Giustina A.; Bone and joint disorders in acromegaly. Neuroendocrinology 2016,103(1),86-95","journal-title":"Neuroendocrinology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1445-5994.1988.tb02236.x","volume":"18","author":"Podgorski M.","year":"1988","unstructured":"Podgorski M.; Robinson B.; Weissberger A.; Stiel J.; Wang S.; Brooks P.M.; Articular manifestations of acromegaly. Aust N Z J Med 1988,18(1),28-35","journal-title":"Aust N Z J Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2337\/diab.31.8.663","volume":"31","author":"Rizza R.A.","year":"1982","unstructured":"Rizza R.A.; Mandarino L.J.; Gerich J.E.; Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 1982,31(8),663-669","journal-title":"Diabetes"},{"key":"ref=64","first-page":"3395","volume":"80","author":"Melmed S.","year":"1995","unstructured":"Melmed S.; Ho K.; Klibanski A.; Reichlin S.; Thorner M.; Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 1995,80(12),3395-3402","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1210\/jcem-27-10-1418","volume":"27","author":"S&#xF6;nksen P.H.","year":"1967","unstructured":"S&#xF6;nksen P.H.; Greenwood F.C.; Ellis J.P.; Lowy C.; Rutherford A.; Nabarro J.D.N.; Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment. J Clin Endocrinol Metab 1967,27(10),1418-1430","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000182185","volume":"36","author":"M&#xF8;ller N.","year":"1991","unstructured":"M&#xF8;ller N.; J&#xF8;rgensen J.O.L.; Abildg&#xE4;rd N.; &#xD8;rskov L.; Schmitz O.; Christiansen J.S.; Effects of growth hormone on glucose metabolism. Horm Res 1991,36(1),32-35","journal-title":"Horm Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1530\/acta.0.1290151","volume":"129","author":"Hoogenberg K.","year":"1993","unstructured":"Hoogenberg K.; Sluiter W.I.; Dullaart R.P.F.; Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency. Eur J Endocrinol 1993,129(2),151-157","journal-title":"Eur J Endocrinol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1210\/jc.2010-2721","volume":"96","author":"Manara R.","year":"2011","unstructured":"Manara R.; Maffei P.; Citton V.; Rizzati S.; Bommarito G.; Ermani M.; Albano I.; Della Puppa A.; Carollo C.; Pavesi G.; Scanarini M.; Ceccato F.; Sicolo N.; Mantero F.; Scaroni C.; Martini C.; Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. J Clin Endocrinol Metab 2011,96(5),1292-1300","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11102-012-0385-9","volume":"16","author":"Manara R.","year":"2013","unstructured":"Manara R.; Bommarito G.; Rizzati S.; Briani C.; Puppa A.D.; Citton V.; Zanchetta E.; Zerbo F.; Ermani M.; Martini C.; Mantero F.; Sicolo N.; Maffei P.; Scaroni C.; Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact. Pituitary 2013,16(1),122-130","journal-title":"Pituitary"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje.0.1510439","volume":"151","author":"Mestr&#xF3;n A.","year":"2004","unstructured":"Mestr&#xF3;n A.; Webb S.M.; Astorga R.; Benito P.; Catal&#xE1; M.; Gaztambide S.; G&#xF3;mez J.M.; Halper&#xED;n I.; Lucas M.T.; Moreno B.; Obiols G.; De Pablos P.; Paramo C.; Pico A.; Torres E.; Varela C.; Vazquez J.A.; Zamora J.; Albareda M.; Gilabert M.; Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 2004,151(4),439-446","journal-title":"Eur J Endocrinol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2176\/nmc.33.547","volume":"33","author":"Kameyama S.","year":"1993","unstructured":"Kameyama S.; Tanaka R.; Hasegawa A.; Tamura T.; Kuroki M.; Subclinical carpal tunnel syndrome in acromegaly. Neurol Med Chir 1993,33(8),547-551","journal-title":"Neurol Med Chir"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/BF03346442","volume":"31","author":"Giustina A.","year":"2008","unstructured":"Giustina A.; Gola M.; Colao A.; De Marinis L.; Losa M.; Sicolo N.; Ghigo E.; The management of the patient with acromegaly and headache: A still open clinical challenge. J Endocrinol Invest 2008,31(10),919-924","journal-title":"J Endocrinol Invest"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1022145116901","volume":"5","author":"Pantanetti P.","year":"2002","unstructured":"Pantanetti P.; Sonino N.; Arnaldi G.; Boscaro M.; Self image and quality of life in acromegaly. Pituitary 2002,5(1),17-19","journal-title":"Pituitary"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.17219\/acem\/38156","volume":"24","author":"Szcze&#x15B;niak D.","year":"2015","unstructured":"Szcze&#x15B;niak D.; Jawiarczyk P.A.; Rymaszewska J.; The quality of life and psychological, social and cognitive functioning of patients with acromegaly. Adv Clin Exp Med 2015,24(1),167-172","journal-title":"Adv Clin Exp Med"},{"key":"ref=75","first-page":"255","volume":"70","author":"Pereira A.M.","year":"2012","unstructured":"Pereira A.M.; Tiemensma J.; Romijn J.A.; Biermasz N.R.; Cognitive impairment and psychopathology in patients with pituitary diseases. Neth J Med 2012,70(6),255-260","journal-title":"Neth J Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"540398","DOI":"10.1155\/2012\/540398","volume":"2012","author":"Lugo G.","year":"2012","unstructured":"Lugo G.; Pena L.; Cordido F.; Clinical manifestations and diagnosis of acromegaly. Int J Endocrinol 2012,2012,540398","journal-title":"Int J Endocrinol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.3748\/wjg.14.3484","volume":"14","author":"Rokkas T.","year":"2008","unstructured":"Rokkas T.; Pistiolas D.; Sechopoulos P.; Margantinis G.; Koukoulis G.; Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis. World J Gastroenterol 2008,14(22),3484-3489","journal-title":"World J Gastroenterol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"e88787","DOI":"10.1371\/journal.pone.0088787","volume":"9","author":"Wolinski K.","year":"2014","unstructured":"Wolinski K.; Czarnywojtek A.; Ruchala M.; Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly--Meta-analysis and systematic review. PLoS One 2014,9(2),e88787","journal-title":"PLoS One"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000095531","volume":"83","author":"Jenkins P.J.","year":"2006","unstructured":"Jenkins P.J.; Cancers associated with acromegaly. Neuroendocrinology 2006,83(3-4),218-223","journal-title":"Neuroendocrinology"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/oxfordjournals.qjmed.a068816","volume":"86","author":"Bates A.S.","year":"1993","unstructured":"Bates A.S.; Van\u2019t Hoff W.; Jones J.M.; Clayton R.N.; An audit of outcome of treatment in acromegaly. QJM. Int J med 1993,86(5),293-299","journal-title":"Int J med"},{"key":"ref=81","first-page":"1","volume":"39","author":"Wright A.D.","year":"1970","unstructured":"Wright A.D.; Hill D.M.; LOWY C.; Fraser T. R.; Mortality in acromegaly1. QJM. Int J Med 1970,39(1),1-16 https:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.887.37 47andrep=rep1andtype=pdf","journal-title":"Int J Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","volume":"12","author":"Alexander L.","year":"1980","unstructured":"Alexander L.; Appleton D.; Hall R.; Ross W.M.; Wilkinson R.; Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 1980,12(1),71-79","journal-title":"Clin Endocrinol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0954-6820.1988.tb15882.x","volume":"223","author":"Thuesen L.","year":"1988","unstructured":"Thuesen L.; Christensen S.; Weeke J.; &#xD8;rskov H.; Henningsen P.; A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients? Acta Med Scand 1988,223(4),337-343","journal-title":"Acta Med Scand"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1210\/jc.83.8.2730","volume":"83","author":"Orme S.M.","year":"1998","unstructured":"Orme S.M.; McNally R.J.Q.; Cartwright R.A.; Belchetz P.E.; Group U.K.A.S.; Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab 1998,83(8),2730-2734","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1210\/jc.83.10.3419","volume":"83","author":"Swearingen B.","year":"1998","unstructured":"Swearingen B.; Barker F.G.; Katznelson L.; Biller B.M.K.; Grinspoon S.; Klibanski A.; Moayeri N.; Black P.M.; Zervas N.T.; Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998,83(10),3419-3426","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-12-0084","volume":"167","author":"Arosio M.","year":"2012","unstructured":"Arosio M.; Reimondo G.; Malchiodi E.; Berchialla P.; Borraccino A.; De Marinis L.; Pivonello R.; Grottoli S.; Losa M.; Cannav&#xF2; S.; Minuto F.; Montini M.; Bondanelli M.; De Menis E.; Martini C.; Angeletti G.; Velardo A.; Peri A.; Faustini F.M.; Tita P.; Pigliaru F.; Borretta G.; Scaroni C.; Bazzoni N.; Bianchi A.; Appetecchia M.; Cavagnini F.; Lombardi G.; Ghigo E.; Beck P.P.; Colao A.; Terzolo M.; Predictors of morbidity and mortality in acromegaly: An Italian survey. Eur J Endocrinol 2012,167(2),189-198","journal-title":"Eur J Endocrinol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1210\/jc.2003-031584","volume":"89","author":"Ayuk J.","year":"2004","unstructured":"Ayuk J.; Clayton R.N.; Holder G.; Sheppard M.C.; Stewart P.M.; Bates A.S.; Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 2004,89(4),1613-1617","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"Dekkers O.M.","year":"2008","unstructured":"Dekkers O.M.; Biermasz N.R.; Pereira A.M.; Romijn J.A.; Vandenbroucke J.P.; Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 2008,93(1),61-67","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1210\/jc.85.2.526","volume":"85","author":"Giustina A.","year":"2000","unstructured":"Giustina A.; Barkan A.; Casanueva F.F.; Cavagnini F.; Frohman L.; Ho K.; Veldhuis J.; Wass J.; Von Werder K.; Melmed S.; Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 2000,85(2),526-529","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jcem.83.10.5111","volume":"83","author":"Abosch A.","year":"1998","unstructured":"Abosch A.; Tyrrell J.B.; Lamborn K.R.; Hannegan L.T.; Applebury C.B.; Wilson C.B.; Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998,83(10),3411-3418","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1586\/14737140.6.9s.S47","volume":"6","author":"Stoller W.A.","year":"2006","unstructured":"Stoller W.A.; Changing paradigms in the surgical and medical management of acromegaly. Expert Rev Anticancer Ther 2006,6(1),47-53","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"Giustina A.","year":"2020","unstructured":"Giustina A.; Barkhoudarian G.; Beckers A.; Ben S.A.; Biermasz N.; Biller B.; Boguszewski C.; Bolanowski M.; Bollerslev J.; Bonert V.; Bronstein M.D.; Buchfelder M.; Casanueva F.; Chanson P.; Clemmons D.; Fleseriu M.; Formenti A.M.; Freda P.; Gadelha M.; Geer E.; Gurnell M.; Heaney A.P.; Ho K.K.Y.; Ioachimescu A.G.; Lamberts S.; Laws E.; Losa M.; Maffei P.; Mamelak A.; Mercado M.; Molitch M.; Mortini P.; Pereira A.M.; Petersenn S.; Post K.; Puig D.M.; Salvatori R.; Samson S.L.; Shimon I.; Strasburger C.; Swearingen B.; Trainer P.; Vance M.L.; Wass J.; Wierman M.E.; Yuen K.C.J.; Zatelli M.C.; Melmed S.; Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord 2020,21(4),667-678","journal-title":"Rev Endocr Metab Disord"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4158\/EP.17.4.636","volume":"17","author":"Katznelson L.","year":"2011","unstructured":"Katznelson L.; Atkinson J.L.D.; Cook D.M.; Ezzat S.Z.; Hamrahian A.H.; Miller K.K.; American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly\u20142011 update: Executive summary. Endocr Pract 2011,17(4),636-646","journal-title":"Endocr Pract"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1210\/jc.2002-011841","volume":"87","author":"Melmed S.","year":"2002","unstructured":"Melmed S.; Casanueva F.F.; Cavagnini F.; Chanson P.; Frohman L.; Grossman A.; Ho K.; Kleinberg D.; Lamberts S.; Laws E.; Lombardi G.; Vance M.L.; Werder K.V.; Wass J.; Giustina A.; Guidelines for acromegaly management. J Clin Endocrinol Metab 2002,87(9),4054-4058","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.wjorl.2020.01.005","volume":"6","author":"Hanson M.","year":"2020","unstructured":"Hanson M.; Li H.; Geer E.; Karimi S.; Tabar V.; Cohen M.A.; Perioperative management of endoscopic transsphenoidal pituitary surgery. World J Otorhinolaryngol Head Neck Surg 2020,6(2),84-93","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1477-7819-12-94","volume":"12","author":"Gao Y.","year":"2014","unstructured":"Gao Y.; Zhong C.; Wang Y.; Xu S.; Guo Y.; Dai C.; Zheng Y.; Wang Y.; Luo Q.; Jiang J.; Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis. World J Surg Oncol 2014,12(1),94","journal-title":"World J Surg Oncol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","volume":"159","author":"Chen C.J.","year":"2017","unstructured":"Chen C.J.; Ironside N.; Pomeraniec I.J.; Chivukula S.; Buell T.J.; Ding D.; Taylor D.G.; Dallapiazza R.F.; Lee C.C.; Bergsneider M.; Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir 2017,159(11),2193-2207","journal-title":"Acta Neurochir"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"16289354","DOI":"10.1155\/2012\/386401","volume":"2012","author":"Marquez Y.","year":"2012","unstructured":"Marquez Y.; Tuchman A.; Zada G.; Surgery and radiosurgery for acromegaly: A review of indications, operative techniques, outcomes, and complications. Int J Endocrinol 2012,2012,16289354","journal-title":"Int J Endocrinol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5603\/EP.a2018.0080","volume":"70","author":"Elbaum M.","year":"2019","unstructured":"Elbaum M.; Mizera \u0141.; Bolanowski M.; The real costs of acromegaly: analysis of different therapies. Endokrynol Pol 2019,70(1),74-85","journal-title":"Endokrynol Pol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1172\/JCI39375","volume":"119","author":"Melmed S.","year":"2009","unstructured":"Melmed S.; Acromegaly pathogenesis and treatment. J Clin Invest 2009,119(11),3189-3202","journal-title":"J Clin Invest"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/pgmj.2005.036087","volume":"82","author":"Ayuk J.","year":"2006","unstructured":"Ayuk J.; Sheppard M.C.; Growth hormone and its disorders. Postgrad Med J 2006,82(963),24-30","journal-title":"Postgrad Med J"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/ijms21051682","volume":"21","author":"Gomes P.M.","year":"2020","unstructured":"Gomes P.M.; C&#xE1;rdenas S.J.; &#xC1;lvarez E.C.; Somatostatin analogs in clinical practice: A review. Int J Mol Sci 2020,21(5),1682","journal-title":"Int J Mol Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"132","DOI":"10.17925\/EE.2013.09.02.132","volume":"9","author":"Gariani K.","year":"2010","unstructured":"Gariani K.; Meyer P.; Philippe J.; Implications of somatostatin analogues in the treatment of acromegaly. Eur Endocrinol 2010,9(2),132-135","journal-title":"Eur Endocrinol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3803\/EnM.2019.34.1.53","volume":"34","author":"Chin S.O.","year":"2019","unstructured":"Chin S.O.; Ku C.R.; Kim B.J.; Kim S.W.; Park K.H.; Song K.H.; Oh S.; Yoon H.K.; Lee E.J.; Lee J.M.; Lim J.S.; Kim J.H.; Kim K.J.; Jin H.Y.; Kim D.J.; Lee K.A.; Moon S.S.; Lim D.J.; Shin D.Y.; Kim S.H.; Kwon M.J.; Kim H.Y.; Kim J.H.; Kim D.S.; Kim C.H.; Medical treatment with somatostatin analogues in acromegaly: Position statement. Endocrinol Metab 2019,34(1),53-62","journal-title":"Endocrinol Metab"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ecl.2007.10.002","volume":"37","author":"Shlomo M.","year":"2008","unstructured":"Shlomo M.; Melmed S.; Acromegaly. Endocrinol Metab Clin North Am 2008,37(1),101-22","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.18773\/austprescr.2017.065","volume":"40","year":"2017","unstructured":"New drug: Pegvisomant for acromegaly. Aust Prescr 2017,40(5),199-199","journal-title":"Aust Prescr"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40618-017-0614-1","volume":"40","author":"Giustina A.","year":"2017","unstructured":"Giustina A.; Arnaldi G.; Bogazzi F.; Cannav&#xF2; S.; Colao A.; De Marinis L.; De Menis E.; Degli U.E.; Giorgino F.; Grottoli S.; Lania A.G.; Maffei P.; Pivonello R.; Ghigo E.; Pegvisomant in acromegaly: an update. J Endocrinol Invest 2017,40(6),577-589","journal-title":"J Endocrinol Invest"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000381644","volume":"103","author":"Neggers S.J.C.M.M.","year":"2016","unstructured":"Neggers S.J.C.M.M.; Muhammad A.; Van Der Lely A.J.; Pegvisomant treatment in acromegaly. Neuroendocrinology 2016,103(1),59-65","journal-title":"Neuroendocrinology"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/EC-15-0064","volume":"4","author":"Silverstein J.M.","year":"2015","unstructured":"Silverstein J.M.; Need for improved monitoring in patients with acromegaly. Endocr Connect 2015,4(4),R59-R67","journal-title":"Endocr Connect"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000435776","volume":"103","author":"Hannon M.J.","year":"2016","unstructured":"Hannon M.J.; Barkan A.L.; Drake W.M.; The role of radiotherapy in acromegaly. Neuroendocrinology 2016,103(1),42-49","journal-title":"Neuroendocrinology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0889-8529(18)30209-3","volume":"21","author":"Eastman R.C.","year":"1992","unstructured":"Eastman R.C.; G&#xF6;rden P.; Glatstein E.; Roth J.; Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 1992,21(3),693-712","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fendo.2017.00040","volume":"8","author":"Geraedts V.J.","year":"2017","unstructured":"Geraedts V.J.; Andela C.D.; Stalla G.K.; Pereira A.M.; Van Furth W.R.; Sievers C.; Biermasz N.R.; Predictors of quality of life in acromegaly: No consensus on biochemical parameters. Front Endocrinol 2017,8,40","journal-title":"Front Endocrinol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"e00229","DOI":"10.1002\/edm2.229","volume":"4","author":"Ballesteros H.D.","year":"2021","unstructured":"Ballesteros H.D.; Brise&#xF1;o H.P.; P&#xE9;rez E,R.; Portocarrero O.L.A.; Differences in quality of life between genders in acromegaly. Endocrinol Diabetes Metab 2021,4(2),e00229","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"819330","DOI":"10.3389\/fendo.2022.819330","volume":"13","author":"Yamamoto N.","year":"2022","unstructured":"Yamamoto N.; Urai S.; Fukuoka H.; Yamamoto M.; Yoshida K.; Suzuki M.; Shichi H.; Fujita Y.; Kanie K.; Iguchi G.; Takahashi Y.; Ogawa W.; The effect of aging on quality of life in acromegaly patients under treatment. Front Endocrinol (Lausanne) 2022,13,819330","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/IJGM.S38594","volume":"6","author":"Adelman D.","year":"2013","unstructured":"Adelman D.; Liebert K.J.; Nachtigall L.B.; Lamerson M.; Bakker B.; Acromegaly: The disease, its impact on patients, and managing the burden of long-term treatment. Int J Gen Med 2013,6,31-38","journal-title":"Int J Gen Med"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.eprac.2021.12.017","volume":"28","author":"Lim D.S.T.","year":"2022","unstructured":"Lim D.S.T.; Fleseriu M.; Personalized medical treatment of patients with acromegaly: A review. Endocr Pract 2022,28(3),321-332","journal-title":"Endocr Pract"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000375451","volume":"103","author":"Webb S.M.","year":"2016","unstructured":"Webb S.M.; Badia X.; Quality of life in acromegaly. Neuroendocrinology 2016,103(1),106-111","journal-title":"Neuroendocrinology"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4103\/ijem.IJEM_401_20","volume":"24","author":"Oliveira B.A.","year":"2020","unstructured":"Oliveira B.A.; Ara&#xFA;jo B.; Dos Santos T.M.; Ongaratti B.R.; Le&#xE3;es R.C.G.S.; Ferreira N.P.; Pereira S.L.J.F.; Da C.; Oliveira, M. Health-related quality of life in acromegaly patients: Results from generic and disease-specific questionnaires. Indian J Endocrinol Metab 2020,24(5),402-405","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4183\/aeb.2021.42","volume":"17","author":"Sc&#xE2;nteie C.","year":"2021","unstructured":"Sc&#xE2;nteie C.; Leucu\u0163a D.C.; Ghervan C.M.V.; Quality of life in patients with acromegaly \u2013 A Romanian single center cross-sectional study. Acta Endocrinol (Bucur) 2021,17(1),42-50","journal-title":"Acta Endocrinol (Bucur)"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11102-016-0761-y","volume":"20","author":"Crespo I.","year":"2017","unstructured":"Crespo I.; Valassi E.; Webb S.M.; Update on quality of life in patients with acromegaly. Pituitary 2017,20(1),185-188","journal-title":"Pituitary"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e937","DOI":"10.1210\/clinem\/dgz096","volume":"105","author":"Giustina A.","year":"2020","unstructured":"Giustina A.; Barkan A.; Beckers A.; Biermasz N.; Biller B.M.K.; Boguszewski C.; Bolanowski M.; Bonert V.; Bronstein M.D.; Casanueva F.F.; Clemmons D.; Colao A.; Ferone D.; Fleseriu M.; Frara S.; Gadelha M.R.; Ghigo E.; Gurnell M.; Heaney A.P.; Ho K.; Ioachimescu A.; Katznelson L.; Kelestimur F.; Kopchick J.; Krsek M.; Lamberts S.; Losa M.; Luger A.; Maffei P.; Marazuela M.; Mazziotti G.; Mercado M.; Mortini P.; Neggers S.; Pereira A.M.; Petersenn S.; Puig-Domingo M.; Salvatori R.; Shimon I.; Strasburger C.; Tsagarakis S.; van der Lely A.J.; Wass J.; Zatelli M.C.; Melmed S.; A consensus on the diagnosis and treatment of acromegaly comorbidities: An update. J Clin Endocrinol Metab 2020,105(4),e937-e946","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/PRBM.S183950","volume":"12","author":"Solomon E.","year":"2019","unstructured":"Solomon E.; Br\u0103ni\u0219teanu D.; Dumbrav\u0103 A.; Solomon R.G.; Kiss L.; Glod M.; Preda C.; Executive functioning and quality of life in acromegaly. Psychol Res Behav Manag 2019,12,39-44","journal-title":"Psychol Res Behav Manag"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-2-13","volume":"2","author":"Badia X.","year":"2004","unstructured":"Badia X.; Webb S.M.; Prieto L.; Lara N.; Acromegaly quality of life questionnaire (AcroQoL). Health Qual Life Outcomes 2004,2(1),13","journal-title":"Health Qual Life Outcomes"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40359-022-00781-0","volume":"10","author":"Danaei M.","year":"2022","unstructured":"Danaei M.; Bahadorizadeh L.; Dehnad A.; Mohamadzadeh S.; Hashemi M.N.; Khamseh M.E.; Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population. BMC Psychol 2022,10(1),63","journal-title":"BMC Psychol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1210\/clinem\/dgaa750","volume":"106","author":"Guo X.","year":"2021","unstructured":"Guo X.; Wang K.; Yu S.; Gao L.; Wang Z.; Zhu H.; Xing B.; Zhang S.; Dong D.; Quality of life and its determinants in patients with treated acromegaly: A cross-sectional nationwide study in China. J Clin Endocrinol Metab 2021,106(1),211-225","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11102-015-0681-2","volume":"19","author":"Giustina A.","year":"2016","unstructured":"Giustina A.; Bevan J.S.; Bronstein M.D.; Casanueva F.F.; Chanson P.; Petersenn S.; Thanh X.M.T.; Sert C.; Houchard A.; Guillemin I.; Melmed S.; SAGIT&#xAE;: Clinician-reported outcome instrument for managing acromegaly in clinical practice-development and results from a pilot study. Pituitary 2016,19(1),39-49","journal-title":"Pituitary"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"dgab536","DOI":"10.1210\/clinem\/dgab536","volume":"106","author":"Giustina A.","year":"2021","unstructured":"Giustina A.; Bronstein M.D.; Chanson P.; Petersenn S.; Casanueva F.F.; Sert C.; Houchard A.; Melmed S.; International multicenter validation study of the SAGIT&#xAE; instrument in acromegaly. J Clin Endocrinol Metab 2021,106(12),dgab536","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1507\/endocrj.EJ16-0182","volume":"64","author":"Fujio S.","year":"2017","unstructured":"Fujio S.; Arimura H.; Hirano H.; Habu M.; Bohara M.; Kinoshita Y.; Arita K.; Changes in quality of life in patients with acromegaly after surgical remission\u2014A prospective study using Sf-36 questionnaire. Endocr J 2017,64(1),27-38","journal-title":"Endocr J"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s11102-017-0835-5","volume":"20","author":"Van Der Lely A.J.","year":"2017","unstructured":"Van Der Lely A.J.; Gomez R.; Pleil A.; Badia X.; Brue T.; Buchfelder M.; Burman P.; Clemmons D.; Ghigo E.; J&#xF8;rgensen J.O.L.; Luger A.; Van Der Lans B.J.; Webb S.M.; Strasburger C.J.; Development of ACRODAT&#xAE;, a new software medical device to assess disease activity in patients with acromegaly. Pituitary 2017,20(6),692-701","journal-title":"Pituitary"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12020-021-02900-0","volume":"75","author":"Marazuela M.","year":"2022","unstructured":"Marazuela M.; Blanco C.; Bernabeu I.; Menendez E.; Villar R.; Paja M.; Sampedro N.M.; Samaniego M.L.; D&#xED;az M.M.; S&#xE1;nchez C.L.; Acromegaly disease activity according to ACRODAT&#xAE;, a cross-sectional study in Spain: ACROVAL study. Endocrine 2022,75(2),525-536","journal-title":"Endocrine"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1210\/jc.2004-0669","volume":"89","author":"Biermasz N.R.","year":"2004","unstructured":"Biermasz N.R.; Van Thiel S.W.; Pereira A.M.; Hoftijzer H.C.; Van Hemert A.M.; Smit J.W.A.; Romijn J.A.; Roelfsema F.; Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 2004,89(11),5369-5376","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/clinem\/dgab726","volume":"107","author":"Gadelha M.R.","year":"2022","unstructured":"Gadelha M.R.; Wildemberg L.E.; Kasuki L.; The future of somatostatin receptor ligands in acromegaly. J Clin Endocrinol Metab 2022,107(2),297-308","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"512","DOI":"10.5603\/EP.a2021.0075","volume":"72","author":"Bolanowski M.","year":"2021","unstructured":"Bolanowski M.; Hubalewska D.A.; Kos K.B.; Rucha\u0142a M.; Witek P.; Zgliczy\u0144ski W.; Houchard A.; Bartma\u0144ska M.; Quality of life in patients with acromegaly receiving lanreotide autogel: A real-world observational study. Endokrynol Pol 2021,72(5),512-519","journal-title":"Endokrynol Pol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530322666221012155533","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209900\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530322666221012155533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T12:12:56Z","timestamp":1691323976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209900\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530322666221012155533","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}